Efficacy and safety of peptide receptor radionuclide therapy with [177Lu]Lu-DOTA-TATE in 15 patients with progressive treatment-refractory meningioma von Minczeles, Noémie S., Bos, Eelke M., de Leeuw, Reinoud C., Kros, Johan M., Konijnenberg, Mark W., Bromberg, Jacoline E. C., de Herder, Wouter W., Dirven, Clemens M. F., Hofland, Johannes, Brabander, Tessa

Volltext

Peptide Receptor Radionuclide Therapy With Lu-DOTATATE for Symptomatic Control of Refractory Carcinoid Syndrome von Zandee, Wouter T, Brabander, Tessa, Blazevic, Anela, Minczeles, Noemie S, Feelders, Richard A, de Herder, Wouter W, Hofland, Johannes

Volltext

Long-Term Outcomes of Submaximal Activities of Peptide Receptor Radionuclide Therapy with 177Lu-DOTATATE in Neuroendocrine Tumor Patients von Minczeles, Noémie S, de Herder, Wouter W, Feelders, Richard A, Verburg, Frederik A, Hofland, Johannes, Brabander, Tessa

Volltext

Long-Term Outcomes of Submaximal Activities of Peptide Receptor Radionuclide Therapy with 177 Lu-DOTATATE in Neuroendocrine Tumor Patients von Minczeles, Noémie S, de Herder, Wouter W, Feelders, Richard A, Verburg, Frederik A, Hofland, Johannes, Brabander, Tessa

Volltext

Peptide Receptor Radionuclide Therapy With Lu-177-DOTATATE for Symptomatic Control of Refractory Carcinoid Syndrome von Zandee, Wouter T., Brabander, Tessa, Blazevic, Anela, Minczeles, Noemie S., Feelders, Richard A., de Herder, Wouter W., Hofland, Johannes

Volltext

A Clinical Guide to Peptide Receptor Radionuclide Therapy with [sup.177]Lu-DOTATATE in Neuroendocrine Tumor Patients von Becx, Mo, Minczeles, Noémie S, Brabander, Tessa, de Herder, Wouter W, Nonnekens, Julie, Hofland, Johannes

Volltext

A Clinical Guide to Peptide Receptor Radionuclide Therapy with 177Lu-DOTATATE in Neuroendocrine Tumor Patients von Becx, Morticia N., Minczeles, Noémie S., Brabander, Tessa, de Herder, Wouter W., Nonnekens, Julie, Hofland, Johannes

Volltext

Induction therapy with 177Lu-DOTATATE procures long-term survival in locally advanced or oligometastatic pancreatic neuroendocrine neoplasm patients von Minczeles, Noémie S., van Eijck, Casper H. J., van Gils, Marjon J., van Velthuysen, Marie-Louise F., Nieveen van Dijkum, Els J. M., Feelders, Richard A., de Herder, Wouter W., Brabander, Tessa, Hofland, Johannes

Volltext

Peptide Receptor Radionuclide Therapy With 177Lu-DOTATATE for Symptomatic Control of Refractory Carcinoid Syndrome von Zandee, Wouter T, Brabander, Tessa, Blažević, Anela, Minczeles, Noémie S, Feelders, Richard A, de Herder, Wouter W, Hofland, Johannes

Volltext

A Clinical Guide to Peptide Receptor Radionuclide Therapy with 177 Lu-DOTATATE in Neuroendocrine Tumor Patients von Becx, Morticia N, Minczeles, Noémie S, Brabander, Tessa, de Herder, Wouter W, Nonnekens, Julie, Hofland, Johannes

Volltext

Induction therapy with 177 Lu-DOTATATE procures long-term survival in locally advanced or oligometastatic pancreatic neuroendocrine neoplasm patients von Minczeles, Noémie S, van Eijck, Casper H J, van Gils, Marjon J, van Velthuysen, Marie-Louise F, Nieveen van Dijkum, Els J M, Feelders, Richard A, de Herder, Wouter W, Brabander, Tessa, Hofland, Johannes

Volltext